Christopher Stauffer, MD
Chris Stauffer received his MD from Oregon Health & Science University in 2010 and completed his Adult Psychiatry Residency at the University of California, San Francisco (UCSF) in 2014. He also completed a post-graduate Psychiatry Research Fellowship at the San Francisco VA Medical Center (SFVAMC). He is currently Assistant Adjunct Professor at UCSF, is the recipient of a VA Career Development Award, and is dual board-certified in Psychiatry and Addiction Medicine. Clinically, he specializes in the treatment of substance use disorders and posttraumatic stress disorder. His research combines clinical psychiatry, social neuroscience, and attachment theory; specifically, he investigates the use of social psychopharmacology - such as oxytocin, MDMA, and psilocybin - as an adjunct to psychotherapy for substance use disorders and PTSD. Dr. Stauffer is the Principal Investigator of several clinical trials using intranasal oxytocin to enhance treatment for substance use disorders. He is sub-investigator and study therapist for the Phase 3 trials of MDMA-assisted psychotherapy for severe PTSD funded by the Multidisciplinary Association of Psychedelic Studies (MAPS) and for a Phase 2 trial of psilocybin-enhanced psychotherapy for demoralization in longterm AIDS survivors, both taking place at UCSF.